Medical Packaging results, Q4 2024
Net profit, assets, equity and cash flow for Q4 2024, against the same period a year earlier, from the published financial statements.
Net profit1.51 millionEGP · −83.7% vs the same period a year earlier
Total assets233 millionEGP · +23.0% vs the same period a year earlier
Shareholders' equity195 millionEGP · +20.7% vs the same period a year earlier
Operating cash flow2.82 millionEGP · −86.4% vs the same period a year earlier
In short
- Medical Packaging's net profit for Q4 2024 was about 1.51 million EGP, down −83.7% from 9.26 million EGP in Q4 2023.
- Total assets at the end of Q4 2024 were about 233 million EGP, and shareholders' equity about 195 million EGP.
- Operating cash flow for Q4 2024 was positive at 2.82 million EGP.
Key lines against the same period a year earlier
This periodQ4 2023Change
Net profit1.51 million9.26 million−83.7%
Gross profit12.44 million21.43 million−41.9%
Total assets233 million190 million+23.0%
Total liabilities38.05 million28 million+35.9%
Shareholders' equity195 million162 million+20.7%
Total liabilities and equity233 million190 million+23.0%
Operating cash flow2.82 million20.75 million−86.4%
Investing cash flow-14.52 million-248 thousand−5760.0%
Financing cash flow1.8 million-1.61 million+212.2%
Net change in cash-9.9 million18.9 million−152.4%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Medical Packaging's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy